Pharmacogenetics to Avoid Adverse Drug Reactions

Pharmacogenetics to Avoid Adverse Drug Reactions

Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This b...

Full description

Saved in:
Bibliographic Details
Sonstige:
López-Fernández, Luis A.
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (220 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546039004498
ctrlnum (CKB)5400000000045301
(oapen)https://directory.doabooks.org/handle/20.500.12854/79654
(EXLCZ)995400000000045301
collection bib_alma
record_format marc
spelling López-Fernández, Luis A. edt
Pharmacogenetics to Avoid Adverse Drug Reactions
Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
1 electronic resource (220 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This book delves into new advances in pharmacogenetics of cardiovascular, cancer, and nervous system drugs. It may be useful for clinicians and patients to understand the basics of pharmacogenetics.
English
Medicine bicssc
5-fluorouracil
capecitabine
fluoropyrimidine
thymidylate synthase
thymidylate synthase enhancer region
upstream stimulatory factor 1
adverse drug reactions
pharmacogenomics
epistasis
random forest
statin
cardiovascular disease
colorectal cancer
personalised medicine
toxicity
(es)citalopram
drug-gene-interaction
drug-drug-interaction
drug-drug-gene-interaction
the PharmLines initiative
antipsychotic agents
pharmacogenetics
cytochrome P-450 enzyme system
psychotic disorders
precision medicine
direct oral anticoagulants
clinical implementation
atorvastatin
SLCO1B1
HLA
cutaneous adverse drug reaction
SCAR
genetic polymorphism
antiepileptics
CYP450 enzymes
platelet reactivity
single-nucleotide variants
acute coronary syndrome
clopidogrel
genotype
allele
polymorphism
HLA B
CYP2C9*3
cutaneous adverse drug reactions (CADRs)
anti-epileptic drugs (AEDS)
phenytoin (PHT)
genetic risk factors
South India
India
cardiology
adverse events
guidelines
3-0365-3344-3
3-0365-3343-5
López-Fernández, Luis A. oth
language English
format eBook
author2 López-Fernández, Luis A.
author_facet López-Fernández, Luis A.
author2_variant l a l f lal lalf
author2_role Sonstige
title Pharmacogenetics to Avoid Adverse Drug Reactions
spellingShingle Pharmacogenetics to Avoid Adverse Drug Reactions
title_full Pharmacogenetics to Avoid Adverse Drug Reactions
title_fullStr Pharmacogenetics to Avoid Adverse Drug Reactions
title_full_unstemmed Pharmacogenetics to Avoid Adverse Drug Reactions
title_auth Pharmacogenetics to Avoid Adverse Drug Reactions
title_new Pharmacogenetics to Avoid Adverse Drug Reactions
title_sort pharmacogenetics to avoid adverse drug reactions
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2022
physical 1 electronic resource (220 p.)
isbn 3-0365-3344-3
3-0365-3343-5
illustrated Not Illustrated
work_keys_str_mv AT lopezfernandezluisa pharmacogeneticstoavoidadversedrugreactions
status_str n
ids_txt_mv (CKB)5400000000045301
(oapen)https://directory.doabooks.org/handle/20.500.12854/79654
(EXLCZ)995400000000045301
carrierType_str_mv cr
is_hierarchy_title Pharmacogenetics to Avoid Adverse Drug Reactions
author2_original_writing_str_mv noLinkedField
_version_ 1787548717824344064
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03221nam-a2200925z--4500</leader><controlfield tag="001">993546039004498</controlfield><controlfield tag="005">20231214133507.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202203s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045301</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/79654</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045301</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">López-Fernández, Luis A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacogenetics to Avoid Adverse Drug Reactions</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (220 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Adverse drug reactions are one of the major constraints when using drugs. These adverse reactions can impact healthcare systems as strongly as many prevalent diseases. Identifying DNA variants associated with adverse drug reactions can help personalize medicine and sustain healthcare systems. This book delves into new advances in pharmacogenetics of cardiovascular, cancer, and nervous system drugs. It may be useful for clinicians and patients to understand the basics of pharmacogenetics.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">5-fluorouracil</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">capecitabine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluoropyrimidine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thymidylate synthase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thymidylate synthase enhancer region</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">upstream stimulatory factor 1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adverse drug reactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacogenomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epistasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">random forest</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">statin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiovascular disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalised medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">(es)citalopram</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug-gene-interaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug-drug-interaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug-drug-gene-interaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">the PharmLines initiative</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antipsychotic agents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacogenetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytochrome P-450 enzyme system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">psychotic disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">direct oral anticoagulants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical implementation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atorvastatin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SLCO1B1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HLA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous adverse drug reaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SCAR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic polymorphism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiepileptics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CYP450 enzymes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platelet reactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single-nucleotide variants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acute coronary syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clopidogrel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">allele</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polymorphism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HLA B</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CYP2C9*3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cutaneous adverse drug reactions (CADRs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-epileptic drugs (AEDS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phenytoin (PHT)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">South India</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">India</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adverse events</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guidelines</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3344-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3343-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">López-Fernández, Luis A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:55:50 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338144260004498&amp;Force_direct=true</subfield><subfield code="Z">5338144260004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338144260004498</subfield></datafield></record></collection>

Similar Items